Stakeholder list (PDF 119 KB)

Surveillance review proposal (PDF 1.01 MB)

Comments form (MSWord 28 KB)

Stakeholder list - review proposal (PDF 191 KB)

Review proposal (PDF 471 KB)

Surveillance review decision (PDF 699 KB)

Evidence update (PDF 350 KB)

2010/103 New NICE guideline set to encourage healthcare professionals to 'think delirium' and take steps to prevent it (PDF 166 KB)

Remit (PDF 14 KB)

List of stakeholders (PDF 23 KB)

Final scope (PDF 111 KB)

Stakeholder comments on draft scope (PDF 199 KB)

Draft scope for consultation (PDF 119 KB)

Draft scope comments proforma (MSWord 48 KB)

List of stakeholders (PDF 23 KB)

Equalities impact assessment (recommendations) (PDF 29 KB)

GDG membership list (PDF 19 KB)

Delirium GDG minutes: 16 July 2009 (PDF 35 KB)

Delirium GDG minutes: 15 July 2009 (PDF 35 KB)

Delirium GDG minutes: 22 April 2009 (PDF 34 KB)

Delirium GDG minutes: 3-4 July 2008 (PDF 38 KB)

Delirium GDG minutes: 13 November 2008 (PDF 19 KB)

Delirium GDG minutes: 21-22 January 2009 (PDF 20 KB)

Delirium GDG minutes: 4 March 2009 (PDF 87 KB)

Draft full guideline for consultation (PDF 1.85 MB)

Algorithm (PDF 45 KB)

Appendices and contents page (PDF 615 KB)

Appendix D adverse effects - included studies (PDF 233 KB)

Appendix D consequences of - included studies (PDF 155 KB)

Appendix D diagnostic test accuracy - included studies (PDF 182 KB)

Appendix D epidemiology - included studies (PDF 214 KB)

Appendix D non pharmacological risk factors - included studies (PDF 90 KB)

Appendix D pharmacological risk factors - included studies (PDF 49 KB)

Appendix E consequences of cohort studies - methodological quality (PDF 125 KB)

Appendix E diagnostic accuracy tests - methodological quality (PDF 172 KB)

Appendix E epidemiology - methodological quality (PDF 168 KB)

Appendix E non-pharmacological risk factors cohort studies - methodological quality (PDF 44 KB)

Appendix E pharmacological risk factors cohort studies - methodological quality (PDF 29 KB)

Appendix E patient information - methodological quality (PDF 213 KB)

Appendix F consequences of - multivariate risk factors (PDF 185 KB)

Appendix F - non-pharmacological risk factors - multivariate risk factors (PDF 293 KB)

Appendix F pharmacological risk factors - multivariate risk factors (PDF 63 KB)

Appendix G diagnostic test accuracy - excluded studies (PDF 128 KB)

Appendix G adverse effects review - excluded studies (PDF 121 KB)

Appendix G consequences of - excluded studies (PDF 55 KB)

Appendix G epidemiology review - excluded studies (PDF 146 KB)

Appendix G non-pharmacological risk factors - excluded studies (PDF 71 KB)

Appendix G information for patients review - excluded studies (PDF 118 KB)

Appendix G pharmacological risk factors - excluded studies (PDF 55 KB)

Appendix G references to excluded studies (PDF 151 KB)

Appendix K evidence summary - prevention (PDF 34 KB)

Appendix K evidence summary - treatment (PDF 39 KB)

Draft NICE guideline for consultation (PDF 250 KB)

Consultation table and with developers responses (PDF 1.02 MB)

Pre-publication check - stakeholder comments/developer responses (PDF 49 KB)

Full guideline (PDF 3.5 MB)

Appendix A - Scope (PDF 64 KB)

Appendix B - Declaration of Interests (PDF 49 KB)

Appendix C - Search Strategies (PDF 174 KB)

Appendix D - Adverse Effects - Included studies (PDF 121 KB)

Appendix D - Consequences of - Included studies (PDF 155 KB)

Appendix D - Diagnostic Test Accuracy - Included Studies (PDF 182 KB)

Appendix D - Epidemiology - Included studies (PDF 91 KB)

Appendix D - Non pharmacological Risk factor - Included studies (PDF 44 KB)

Appendix D - Pharma Nonpharma Prevention Treatment - Included studies (PDF 170 KB)

Appendix D - Pharmacological Risk factors - Included studies (PDF 49 KB)

Appendix E - Consequences of (PDF 125 KB)

Appendix E - Diagnostic Accuracy Tests Methodological Quality (PDF 172 KB)

Appendix E - Epidemiology quality (PDF 71 KB)

Appendix E - Non Pharmacological Risk Factors (PDF 44 KB)

Appendix E - Patient info quality (PDF 80 KB)

Appendix E - Pharma NonPharma Prevention Treatment (PDF 107 KB)

Appendix E - Pharmacological Risk Factors review - Randomised controlled trials (PDF 23 KB)

Appendix E - Pharmacological Risk Factors review - cohort studies (PDF 30 KB)

Appendix G - References for Excluded Studies (PDF 93 KB)

Appendix H - Recommendations for Future Research (PDF 75 KB)

Appendix I - DSM-IV and Scales For Measuring (PDF 64 KB)

Appendix J - Health Economics (PDF 155 KB)

Appendix K - Forest Plots (PDF 462 KB)